Historical Valuation
agilon health inc (AGL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.05 is considered Undervalued compared with the five-year average of -26.92. The fair price of agilon health inc (AGL) is between 6.73 to 9.49 according to relative valuation methord. Compared to the current price of 0.90 USD , agilon health inc is Undervalued By 86.57%.
Relative Value
Fair Zone
6.73-9.49
Current Price：0.90
86.57%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
agilon health inc (AGL) has a current Price-to-Book (P/B) ratio of 0.91. Compared to its 3-year average P/B ratio of 4.39 , the current P/B ratio is approximately -79.21% higher. Relative to its 5-year average P/B ratio of 3.82, the current P/B ratio is about -76.11% higher. agilon health inc (AGL) has a Forward Free Cash Flow (FCF) yield of approximately -29.49%. Compared to its 3-year average FCF yield of -8.35%, the current FCF yield is approximately 252.99% lower. Relative to its 5-year average FCF yield of -5.78% , the current FCF yield is about 409.94% lower.
P/B
Median3y
4.39
Median5y
3.82
FCF Yield
Median3y
-8.35
Median5y
-5.78
Competitors Valuation Multiple
AI Analysis for AGL
The average P/S ratio for AGL competitors is 1.30, providing a benchmark for relative valuation. agilon health inc Corp (AGL.N) exhibits a P/S ratio of 0.05, which is -96.42% above the industry average. Given its robust revenue growth of -1.08%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for AGL
1Y
3Y
5Y
Market capitalization of AGL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AGL in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AGL currently overvalued or undervalued?
agilon health inc (AGL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.05 is considered Undervalued compared with the five-year average of -26.92. The fair price of agilon health inc (AGL) is between 6.73 to 9.49 according to relative valuation methord. Compared to the current price of 0.90 USD , agilon health inc is Undervalued By 86.57% .
What is agilon health inc (AGL) fair value?
AGL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of agilon health inc (AGL) is between 6.73 to 9.49 according to relative valuation methord.
How does AGL's valuation metrics compare to the industry average?
The average P/S ratio for AGL's competitors is 1.30, providing a benchmark for relative valuation. agilon health inc Corp (AGL) exhibits a P/S ratio of 0.05, which is -96.42% above the industry average. Given its robust revenue growth of -1.08%, this premium appears unsustainable.
What is the current P/B ratio for agilon health inc (AGL) as of Jan 10 2026?
As of Jan 10 2026, agilon health inc (AGL) has a P/B ratio of 0.91. This indicates that the market values AGL at 0.91 times its book value.
What is the current FCF Yield for agilon health inc (AGL) as of Jan 10 2026?
As of Jan 10 2026, agilon health inc (AGL) has a FCF Yield of -29.49%. This means that for every dollar of agilon health inc’s market capitalization, the company generates -29.49 cents in free cash flow.
What is the current Forward P/E ratio for agilon health inc (AGL) as of Jan 10 2026?
As of Jan 10 2026, agilon health inc (AGL) has a Forward P/E ratio of -1.07. This means the market is willing to pay $-1.07 for every dollar of agilon health inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for agilon health inc (AGL) as of Jan 10 2026?
As of Jan 10 2026, agilon health inc (AGL) has a Forward P/S ratio of 0.05. This means the market is valuing AGL at $0.05 for every dollar of expected revenue over the next 12 months.